Mounjaro’s been great,” the comedian said in an Instagram video. “I’m having a really good experience with it and I wanted to ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the price of its weight loss drug by more than half ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...

Novo Nordisk said Monday that it had entered into a license agreement with a Chinese company developing a competitor to ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Lilly beats Novo Nordisk to launch weight-loss drug ... Novo's stock has fallen over 12% so far this year, while Lilly's has jumped 8%. The active ingredient in Wegovy is semaglutide, which ...

Hims and Hers' stock fell over 19% in after-hours ... has been making legal copies of Novo Nordisk's weight loss and diabetes drugs Ozempic and Wegovy during a shortage that began in 2022.

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...